Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 3

Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome

Pages
282–287
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In our study, we conclude that non-dipper HT increases the number of lesions, MI cases at night, and MACEratios in CAD by causing endothelium dysfunction and stimulating thrombocyte activation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: During sleep, blood pressure (BP) is generally 10%–20% lower, and the risk of target organ damage in non-dip per hypertension (HT) is related to left ventricle hypertrophy, MI, and stroke.
📊
Key Findings & Data:Materials and Methods: We included 107 patients who were diagnosed with ACS and had angina pectoris lasting 12 h atmost and no history of CAD in this study.
💡
Conclusion & Impact:Conclusion: In our study, we conclude that non-dipper HT increases the number of lesions, MI cases at night, and MACEratios in CAD by causing endothelium dysfunction and stimulating thrombocyte activation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: During sleep, blood pressure (BP) is generally 10%–20% lower, and the risk of target organ damage in non-dip per hypertension (HT) is related to left ventricle hypertrophy, MI, and stroke. This study aimed to analyze the effect ofnon-dipper HT on the prevalence of coronary artery disease (CAD), time of symptom onset, and in-hospital MACE in pa tients with acute coronary syndrome (ACS). Materials and Methods: We included 107 patients who were diagnosed with ACS and had angina pectoris lasting 12 h atmost and no history of CAD in this study. Patients’ ambulatory BP was monitored for 24 h. Patients were divided into thenon-hipper and dipper groups according to the decrease in BP during nighttime. We compared the prevalence of CAD, timeof symptom onset, and in-hospital MACE in both groups. Results: We included 52 patients in the non-dipper group and 55 patients in the dipper group in this study. When wecompared the Syntax and Gensini scores between the groups, statistical significance was determined (p=0.006). In terms ofsymptom onset hours, 32 (62%) and 19 (35%) patients were admitted with night angina pectoris in the non-dipper and dip per groups, respectively (p=0.007). In terms of in-hospital MACE ratios, we identified MACE in six patients in the non-dippergroup and three patients in the dipper group (p=0.223). Conclusion: In our study, we conclude that non-dipper HT increases the number of lesions, MI cases at night, and MACEratios in CAD by causing endothelium dysfunction and stimulating thrombocyte activation.

🔖

Cite This Article

TOPSAKAL, R., KELEŞOĞLU, Ş., OĞUZHAN, A., DOĞAN, A., KALAY, N., ELÇİK, D., BİNGÖL, B., ÇETİNKAYA, Z., İİNANÇ, M. T. (2022). Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. Erciyes Medical Journal, Cilt: 43 - Sayı: 3, 282–287. https://ajindex.com/articles/502255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. White HD, Chew DP. Acute myocardial infarction. Lancet 2008; 372(9638): 570–84
  2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104(3): 365–72
  3. Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Collantes E, Aguirre MA, Perez-Sanchez C. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. Front Immunol 2019; 10: 764
  4. Holm NR, Mäkikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 2020; 395(10219): 191–9
  5. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020; 16(4): 223–37
  6. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of bloodpressure. Lancet 1978; 1(8068): 795–7
  7. Seo WS, Oh HS. The circadian rhythms of blood pressure and heart rate in the hypertensive subjects: dippers and non-dippers. Yonsei Med J 2002; 43(3): 320–8
  8. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42(3): 283–90
  9. Pierdomenico SD, Costantini F, Bucci A, De Cesare D, Bucciarelli T, Cuccurullo F, et al. Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. Am J Hypertens 1999; 12(4 Pt 1): 356–63
  10. Takeda A, Toda T, Fujii T, Matsui N. Bedtime administration of longacting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension. Clin Exp Nephrol 2009; 13(5): 467–72
  11. Murphy JG. Mayo clinic Cardiology review. The Endothelium. 2nd edition. Lippincott Williams & Wilkins 2001.p. 99–106
  12. Landmesser U, Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol 2005; 20(6): 547–51
  13. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 1999; 33(1): 29–35
  14. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20(1